Table 3 Drugs used for treatment of allergic rhinitis, urticaria and atopic eczema in children and their authorizations for their use according to age, dose and indication

Allergic Rhinitis

6 years

6 years

400 μg/day

400 μg/day

4 years

4 years

50 μg/day – 4 to 12 years

200 μg/day

200 μg/day ≥ 12 years

6 years

2 years

100 μg/day

100 μg/day -2 to 11 years;

200 μg/day ≥ 12 years

Allergic rhinitis; Urticaria

2 years

6 months

5 mg/day – 2 to 6 years;

2.5 mg/day- 6 months to 1year

10 mg/day > 6 years

5 mg/day- >1 year to 5 years

10 mg ≥ 6 years

2 years

6 months

2.5 mg/day – 2 to 6 years;

1.25 mg 6 months to 5 years

5 mg/day – older than 6 years

2.5 mg- 6 years to 11 years

5 mg ≥ 12 years

2 years

2 years

5 mg/day – 2 to 6 years;

10 mg/day > 6 years

12 months

6 months

1.25 mg/day – 1 to 5 years;

1 mg – 6 to 11 months

2.5 mg/day – 6 to 12 years;

1.25 mg/day – 1 to 5 years;

5 mg/day ≥ 12 years;

2.5 mg/day – 6 to 11 years;

5 mg/day ≥ 12 years

6 years

6 years

60 mg/day – 6 to 11 years

30 mg/day- 6 months to < 2 years

180 mg/day ≥ 12 years

60 mg/day – 2 to 11 years

180 mg/day ≥ 12 years

6 years

2 years

75 mg/day – 6 to 12 years;

37.5 mg/day – 2 to 5 years

150 mg/day > 12 years

150 mg/day – 6 to 11 years

300 mg/day ≥ 12 years

Atopic Dermatitis

2 years

2 years

Twice daily, intermittent treatment 12 months

Twice daily, intermittent treatment 12 months

2 years

2 years

0.03%- 2 to 15 years

0.03% – 2 to 15 years

0.1% ≥ 16 years

0.1% ≥ 16 years

(twice daily for 3 weeks then once daily, intermittent use)

(twice daily for intermittent use)